Table 1.
Clinico‐pathological parameters of the BC samples.
| Clinicopathologicalparameters | Samples | Mean age (years) | Age range (years) | ER/PR statusa | ||
|---|---|---|---|---|---|---|
| Positive | Negative | P value | ||||
| Gender | ||||||
| Female | 101 | 44 | 20–77 | 21 (35%) | 39 (65%) | N/A |
| Male | 3 | 52 | 45–60 | 0 | 0 | |
| Histological type | ||||||
| Ductal | 102 | 44 | 23–77 | 21 (35%) | 39 (65%) | N/A |
| Lobular | 2 | 28 | 20–35 | 0 | 0 | |
| Age at diagnosis | ||||||
| ≤40 years | 47 | 34 | 20–40 | 6 (25%) | 18 (75%) | 0.18 |
| >40 years | 59 | 50 | 42–77 | 15 (42%) | 21 (58%) | |
| Clinical stages | ||||||
| Stage I | 3 | 44 | 45–50 | 1 (100%) | 0 | |
| Stage II | 28 | 42 | 23–61 | 14 (64%) | 8 (36%) | 0.001 b |
| Stage III | 69 | 44 | 20–77 | 6 (18%) | 27 (82%) | |
| Stage IV | 6 | 47 | 32–72 | 0 | 4 (100%) | |
| Lymph node status | ||||||
| Positive | 81 | 44 | 28–77 | 13 (37%) | 35 (63%) | 0.01 b |
| Negative | 25 | 41 | 20–61 | 8 (67%) | 4 (33%) | |
| Tumor grade | ||||||
| Grade I | 12 | 42 | 20–61 | 4 (67%) | 2 (33%) | |
| Grade II | 71 | 40 | 23–72 | 16 (55%) | 13 (45%) | 0.0001 b |
| Grade III | 23 | 47 | 30–77 | 1 (4%) | 24 (96%) | |
N/A, not applicable.
a
ER/PR status were determined for 60 samples.
b
The P values in bold indicate significant correlation (≤0.05).